<DOC>
	<DOCNO>NCT00536783</DOCNO>
	<brief_summary>The purpose study use magnetoencephalography MEG ( machine measure magnetic activity brain ) electroencephalography EEG ( technique measure electrical activity brain ) study sound processed individual schizophrenia three month take antipsychotic medication quetiapine .</brief_summary>
	<brief_title>Schizophrenia Sensory Gating Deficit With Quetiapine</brief_title>
	<detailed_description>.Problems attention perception core feature schizophrenia hypothesize result defect filter gate sensory input . Examination require neuoimaging technique high temporal resolution . High-density EEG MEG combination structural magnetic resonance imaging ( sMRI ) use map sensory gating . In number recent study patient treat novel antipsychotic show P50 gate ratio resemble normal control rather schizophrenia subject treatment conventional antipsychotic . To date , literature effect quetiapine sensory gating . Subjects meet inclusion criterion stable dose quetiapine three month receive clinical interview , MRI , MEG , neuropsychological test determine patient schizophrenia treat quetiapine demonstrate sensory gate ratio similar normal control , indicate deficit sensory gating .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patient Population Diagnosis Schizophrenia determine Structured Clinical Interview DSMIV No comorbid diagnosis PTSD responder quetiapine , determine continuous treatment dose quetiapine absence psychiatric hospitalization least 3 month No history drug dependency lifetime No history alcohol substance abuse 6 month prior entry study No history head injury loss consciousness 5 minute No history seizure disorder No mood stabilize agent Between 1865 Able sign inform consent Normal Controls Matched age gender patient population No history psychiatric dysfunction alcohol substance dependence lifetime determine SCID No history alcohol substance abuse previous 6 month No family history psychotic disorder first degree relative assess FHRDC diagnostic interview No history head injury loss consciousness 5 minute No history seizure disorder Between 1865 Able sign inform consent Subjects exclude participate study : Require treatment mood stabilizer Have inpatient hospitalization past 3 month Have history neurological disorder Have axis I diagnosis besides schizophrenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Psychiatry</keyword>
	<keyword>Antipsychotic</keyword>
	<keyword>Psychopharmacology</keyword>
	<keyword>Clinical Trial</keyword>
	<keyword>Open Label</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Sensory Gating</keyword>
	<keyword>Attention</keyword>
	<keyword>Memory</keyword>
</DOC>